Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127393931 | 12739393 | 1 | I | 20140804 | 20160623 | 20160913 | 20160913 | EXP | JP-JNJFOC-20160625757 | JANSSEN | TOKUMOTO Y, WATANABE T, YOSHIDA O, HIROOKA M, M A, Y H. TREATMENT OUTCOME OF ANTIVIRAL THERAPY FOR RECURRENT CHRONIC HEPATITIS C AFTER LIVER TRANSPLANTATION: A SINGLE CENTER EXPERIENCE. 144 . | 58.00 | YR | A | M | Y | 0.00000 | 20160913 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127393931 | 12739393 | 1 | PS | SOVRIAD | SIMEPREVIR | 1 | Oral | N | 205123 | 100 | MG | CAPSULE | QD | ||||||
127393931 | 12739393 | 2 | SS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Subcutaneous | 0 | 180 | MG | INJECTION | /wk | |||||||
127393931 | 12739393 | 3 | SS | COPEGUS | RIBAVIRIN | 1 | Oral | Y | 0 | 1000 | MG | UNSPECIFIED | QD | ||||||
127393931 | 12739393 | 4 | SS | COPEGUS | RIBAVIRIN | 1 | Oral | Y | 0 | 600 | MG | UNSPECIFIED | QD | ||||||
127393931 | 12739393 | 5 | SS | COPEGUS | RIBAVIRIN | 1 | Oral | Y | 0 | 200 | MG | UNSPECIFIED | QD | ||||||
127393931 | 12739393 | 6 | SS | COPEGUS | RIBAVIRIN | 1 | Oral | Y | 0 | 800 | MG | UNSPECIFIED | QD | ||||||
127393931 | 12739393 | 7 | SS | COPEGUS | RIBAVIRIN | 1 | Oral | Y | 0 | 400 | MG | UNSPECIFIED | QD | ||||||
127393931 | 12739393 | 8 | SS | COPEGUS | RIBAVIRIN | 1 | Oral | Y | 0 | 200 | MG | UNSPECIFIED | QD | ||||||
127393931 | 12739393 | 9 | SS | COPEGUS | RIBAVIRIN | 1 | Oral | Y | 0 | 100 | MG | UNSPECIFIED | QD | ||||||
127393931 | 12739393 | 10 | C | FEBURIC | FEBUXOSTAT | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
127393931 | 12739393 | 11 | C | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
127393931 | 12739393 | 12 | C | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
127393931 | 12739393 | 13 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127393931 | 12739393 | 1 | Antiviral treatment |
127393931 | 12739393 | 2 | Antiviral treatment |
127393931 | 12739393 | 3 | Antiviral treatment |
127393931 | 12739393 | 4 | Antiviral treatment |
127393931 | 12739393 | 5 | Antiviral treatment |
127393931 | 12739393 | 6 | Antiviral treatment |
127393931 | 12739393 | 7 | Antiviral treatment |
127393931 | 12739393 | 8 | Antiviral treatment |
127393931 | 12739393 | 9 | Antiviral treatment |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127393931 | 12739393 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127393931 | 12739393 | Anaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127393931 | 12739393 | 1 | 20140707 | 20140922 | 0 | |
127393931 | 12739393 | 2 | 20140707 | 20141215 | 0 | |
127393931 | 12739393 | 3 | 20140707 | 20140727 | 0 | |
127393931 | 12739393 | 4 | 20141201 | 20141221 | 0 | |
127393931 | 12739393 | 5 | 20141117 | 20141130 | 0 | |
127393931 | 12739393 | 6 | 20140728 | 20140803 | 0 | |
127393931 | 12739393 | 7 | 20140804 | 20140810 | 0 | |
127393931 | 12739393 | 8 | 20140811 | 20140817 | 0 | |
127393931 | 12739393 | 9 | 20140901 | 20141116 | 0 |